Targeted and responsive biomaterials in osteoarthritis
Таргетные и реагирующие биоматериалы при остеоартрите
2023-01-01
SCID: 54.1/ua9ccz3r
Discuss with AI
controlled releasedrug targetingosteoarthritisresponsive biomaterialstargeted biomaterials
Figures from the paper
Abstract (AI)
Osteoarthritis (OA) is a degenerative disease characterized by loss of articular cartilage and chronic inflammation, involving multiple cellular dysfunctions and tissue lesions. The non-vascular environment and dense cartilage matrix in the joints tend to block drug penetration, resulting in low drug bioavailability. There is a desire to develop safer and more effective OA therapies to meet the challenges of an aging world population in the future. Biomaterials have achieved satisfactory results in improving drug targeting, prolonging the duration of action, and achieving precision therapy. This article reviews the current basic understanding of the pathological mechanisms and clinical treatment dilemmas of OA, summarizes and discusses the advances for different kinds of targeted and responsive biomaterials in OA, seeking to provide new perspectives for the treatment of OA. Subsequently, limitations and challenges in clinical translation and biosafety are analyzed to guide the development of future therapeutic strategies for OA. As the need for precision medicine rises over time, emerging multifunctional biomaterials based on tissue targeting and controlled release will become an irreplaceable part of OA management.
Key Findings
1
Multifunctional biomaterials integrating tissue targeting with controlled release are expected to become increasingly important for precision osteoarthritis management.
2
Osteoarthritis involves cartilage loss, chronic inflammation, multiple cellular dysfunctions, and diverse tissue lesions, complicating treatment development.
3
Targeted and responsive biomaterials can improve drug localization, prolong therapeutic action, and enable more precise osteoarthritis treatment.
4
The avascular joint environment and dense cartilage matrix impede drug penetration and reduce local drug bioavailability.
5
The review summarizes advances in tissue-targeted and stimulus-responsive biomaterials for osteoarthritis therapy while identifying clinical translation and biosafety challenges.
Research Object
targeted and responsive biomaterials for osteoarthritis therapy
Research Subject
their tissue targeting, controlled drug release, therapeutic efficacy, and clinical translation challenges in osteoarthritis
Publication Details
Publication Date
2023-01-01
Journal
Publisher
ISSN
Cited by
150
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest